The role of serotonin in the pathophysiology and treatment of schizophrenia.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  The Journal of Neuropsychiatry and Clinical Neurosciences

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1176/JNP.9.1.1PMID 9017523
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

  2009cited by this paper
• Evidence for biochemical heterogeneity in schizophrenia: a multivariate study of monoaminergic indices in human post-mortal brain tissue

  2005cited by this paper
• Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia

  2005cited by this paper
• Differential effects of amphetamine and neuroleptics on negative Vs. positive symptoms in schizophrenia

  2004cited by this paper
• Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

  2004cited by this paper
• Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition

  2004cited by this paper
• Provocative tests with psychostimulant drugs in schizophrenia

  2004cited by this paper
• Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia

  2004cited by this paper
• Therapeutic effect and safety of increasing doses of risperidone (R 64766) in psychotic patients

  2004cited by this paper
• TWO KINDS OF TRYPTAMINE RECEPTOR

  1997cited by this paper
• Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects.

  1996cited by this paper
• Serotonin-dopamine interaction and its relevance to schizophrenia.

  1996cited by this paper
• Comparative localization of serotonin1A, 1C, and 2 receptor subtype mRNAs in rat brain

  1995cited by this paper
• Mode of Action of Atypical Neuroleptics in Relation to the Phencyclidine Model of Schizophrenia: Role of 5‐HT2 Receptor and &agr;1‐Adrenoreceptor Antagonism

  1995cited by this paper
• [3H]Paroxetine Binding Is Altered in the Hippocampus but Not the Frontal Cortex or Caudate Nucleus from Subjects with Schizophrenia

  1995cited by this paper
• Serotonin Depletion in the Adult Rat Causes Loss of the Dendritic Marker MAP-2

  1995cited by this paper
• The selective 5-HT2A receptor antagonist, MDL 100,907, increases dopamine efflux in the prefrontal cortex of the rat.

  1995cited by this paper
• Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.

  1995cited by this paper
• DOI, a 5-HT2A/2C receptor agonist, potentiates amphetamine-induced dopamine release in rat striatum.

  1995cited by this paper
• Mode of action of atypical neuroleptics in relation to the phencyclidine model of schizophrenia: role of 5-HT2 receptor and alpha 1-adrenoceptor antagonism [corrected].

  1995cited by this paper
• SPECT imaging of striatal dopamine release after amphetamine challenge.

  1995cited by this paper
• Blockade of Striatal 5‐Hydroxytryptmine2 Receptors Reduces the Increase in Extracellullar Concentrations of Dopamine Produced by the Amphhetamine analogue 3,4‐Methylenedioxymethamphetamine

  1994cited by this paper
• Neurons Expressing 5-HT2 Receptors in the Rat Brain: Neurochemical Identification of Cell Types by Immunocytochemistry

  1994cited by this paper
• Risperidone in the treatment of schizophrenia.

  1994cited by this paper
• Brain 5-HT2 receptors in suicide victims: violence of death, depression and effects of antidepressant treatment.

  1994cited by this paper
• An open clinical and biochemical study of ritanserin in acute patients with schizophrenia

  1994cited by this paper
• Excitation of interneurons in piriform cortex by 5-hydroxytryptamine: blockade by MDL 100,907, a highly selective 5-HT2A receptor antagonist.

  1994cited by this paper
• Serotonin and the Action of LSD in the Brain

  1994cited by this paper
• International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin).

  1994cited by this paper
• Receptors for 5-hydroxytryptamine: current perspectives on classification and nomenclature.

  1994cited by this paper
• Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors.

  1994cited by this paper
• 5-HT uptake sites and 5-HT2 receptors in brain of antidepressant-free suicide victims/depressives: increase in 5-HT2 sites in cortex and amygdala.

  1993cited by this paper
• m-Chlorophenylpiperazine effects in neuroleptic-free schizophrenic patients. Evidence implicating serotonergic systems in the positive symptoms of schizophrenia.

  1993cited by this paper
• Pyramidal cells in piriform cortex receive a convergence of inputs from monoamine activated GABAergic interneurons.

  1993cited by this paper
• Clozapine attenuates meta-chlorophenylpiperazine (mCPP)-induced plasma cortisol increases in schizophrenia.

  1993cited by this paper
• A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients.

  1993cited by this paper
• Pharmacological and Regional Characterization of [3H]LY278584 Binding Sites in Human Brain

  1993cited by this paper
• Molecular cloning and expression of a 5-hydroxytryptamine7 serotonin receptor subtype.

  1993cited by this paper
• The atypical antipsychotic drug amperozide enhances rat cortical and striatal dopamine efflux.

  1993cited by this paper
• Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.

  1993cited by this paper
• Total nerve cell number in neocortex in chronic schizophrenics and controls estimated using optical disectors.

  1993cited by this paper
• Serotonin 5-HT3 receptors in schizophrenia: a postmortem study of the amygdala.

  1993cited by this paper
• Effect of neuroleptic medication on cerebrospinal fluid monoamine metabolite concentrations in schizophrenia. Serotonin-dopamine interactions as a target for treatment.

  1993cited by this paper
• Characterization of the 5-HT2 receptor antagonist MDL 100907 as a putative atypical antipsychotic: behavioral, electrophysiological and neurochemical studies.

  1993cited by this paper
• Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations

  1993cited by this paper
• Understanding the Mechanism of Action of Atypical Antipsychotic Drugs

  1993cited by this paper
• Serotonin Uptake Sites and Serotonin Receptors Are Altered in the Limbic System of Schizophrenics

  1993cited by this paper
• Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs.

  1993cited by this paper
• Contribution of serotonin neurotoxins to understanding psychiatric disorders: the role of 5‐HT2, receptors in schizophrenia and antipsychotic activity

  1993cited by this paper
• Neurotransmitter regulation of dopamine neurons in the ventral tegmental area.

  1993cited by this paper
• Selective abnormalities of prefrontal serotonergic receptors in schizophrenia. A postmortem study.

  1993cited by this paper
• 5-HT2 receptor-mediated potentiation of dopamine synthesis and central serotonergic deficits.

  1993cited by this paper
• Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4.

  1992cited by this paper
• Serotonin function in schizophrenia: effects of meta-chlorophenylpiperazine in schizophrenic patients and healthy subjects.

  1992cited by this paper
• Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.

  1992cited by this paper
• Regionally specific effects of atypical antipsychotic drugs on striatal Fos expression: The nucleus accumbens shell as a locus of antipsychotic action.

  1992cited by this paper
• Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients: a multicentre double‐blind comparative study

  1992cited by this paper
• Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients

  1991cited by this paper
• Clozapine. A novel antipsychotic agent.

  1991cited by this paper
• The mechanism of action of novel antipsychotic drugs.

  1991cited by this paper
• Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients.

  1991cited by this paper
• Mechanisms of action of atypical antipsychotic drugs. Implications for novel therapeutic strategies for schizophrenia.

  1991cited by this paper
• Effects of the 5-HT2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbens.

  1991cited by this paper
• Excitatory responses to serotonin (5‐HT) in neurons of the rat piriform cortex: Evidence for mediation by 5‐HT1C receptors in pyramidal cells and 5‐HT2 receptors in interneurons

  1991cited by this paper
• Dopamine in schizophrenia: a review and reconceptualization.

  1991cited by this paper
• Depletion of brain serotonin differently affects behaviors induced by 5HT1A, 5HT1C, and 5HT2 receptor activation in rats.

  1991cited by this paper
• The MCPP challenge test in schizophrenia: hormonal and behavioral responses.

  1991cited by this paper
• Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: a hypothesis for the etiology of schizophrenia.

  1991cited by this paper
• Abnormal expression of two microtubule-associated proteins (MAP2 and MAP5) in specific subfields of the hippocampal formation in schizophrenia.

  1991cited by this paper
• Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects.

  1991cited by this paper
• Increase in serotonin 5-HT1A receptors in prefrontal and temporal cortices of brains from patients with chronic schizophrenia.

  1991cited by this paper
• Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine

  1991cited by this paper
• The 5-HT transporter is an additional site of action for the 5-HT agonists RU 24969 and TFMPP

  1991cited by this paper
• m-Chlorophenylpiperazine as a probe of serotonin function.

  1991cited by this paper
• Acute Effects of Typical and Atypical Antipsychotic Drugs on the Release of Dopamine from Prefrontal Cortex, Nucleus Accumbens, and Striatum of the Rat: An In Vivo Microdialysis Study

  1990cited by this paper
• Autoradiographic demonstration of increased serotonin 5-HT2 and beta-adrenergic receptor binding sites in the brain of suicide victims.

  1990cited by this paper
• 5-HT2 antagonist ritanserin in neuroleptic-induced parkinsonism: a double-blind comparison with orphenadrine and placebo.

  1990cited by this paper
• The effect of serotonergic agents on haloperidol-induced catalepsy.

  1990cited by this paper
• Regulation of 5-HT2 and 5-HT1C serotonin receptor levels. Methodology and mechanisms.

  1990cited by this paper
• Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites.

  1990cited by this paper
• Ketanserin pretreatment attenuates MDMA-induced dopamine release in the striatum as measured by in vivo microdialysis.

  1990cited by this paper
• Atypical neuroleptics: role of multiple receptors, endogenous dopamine, and receptor linkage

  1990cited by this paper
• Treatment of neuroleptic induced akathisia with the 5-HT2 antagonist ritanserin.

  1990cited by this paper
• Gaps and peculiarities in 5-HT2 receptor studies.

  1990cited by this paper
• Autoradiographic analysis of [3H]ketanserin binding in the human brain postmortem: effect of suicide.

  1990cited by this paper
• Effects of Fenfluramine on Neuropsychological and: Communicative Functioning in Treatment‐Refractory Schizophrenic Patients

  1990cited by this paper
• Effects of amperozide, a putative antipsychotic drug, on rat midbrain dopamine neurons recorded in vivo.

  1990cited by this paper
• Serotonin microinfusion into the ventral tegmental area increases accumbens dopamine release.

  1989cited by this paper
• Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values.

  1989cited by this paper
• Local cooling of pre-frontal cortex induces pacemaker-like firing of dopamine neurons in rat ventral tegmental area in vivo.

  1989cited by this paper
• The 5-HT2 antagonist ritanserin blocks the effect of pre-frontal cortex inactivation on rat A10 dopamine neurons in vivo.

  1989cited by this paper
• Risperidone in the treatment of chronic schizophrenia with tardive dyskinesia. A single-blind crossover study versus placebo

  1989cited by this paper
• 1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

  1989cited by this paper
• Effects of ICI 169,369, a selective serotonin2 antagonist, in electrophysiological tests predictive of antipsychotic activity.

  1989cited by this paper
• Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects.

  1989cited by this paper
• Thymosthenic Agents, A Novel Approach in the Treatment of Schizophrenia

  1989cited by this paper
• Functional correlates of serotonin 5-HT1 recognition sites.

  1988cited by this paper
• Brain 5-HT2 receptor binding sites in depressed suicide victims.

  1988cited by this paper
• The role of serotonin in schizophrenia.

  1988cited by this paper
• Amphetamine‐Induced Dopamine Release in the Rat Striatum: An In Vivo Microdialysis Study

  1988cited by this paper

• Emerging Neurobiological and Therapeutic Insights into Schizophrenia: A Comprehensive Review.

  2026cites this paper
• Differential Effects of Prenatal Poly I:C Exposure and Antipsychotics on NMDA/GABA Receptors and GSK3β‐Mediated Signaling in the Dorsal Raphe Nucleus of Female Rats

  2025cites this paper
• Sex Differences in Brain Disorders

  2023cites this paper
• Prepulse inhibition of the acoustic startle reflex impairment by 5-HT2A receptor activation in the inferior colliculusis prevented by GABAA receptor blockade in the pedunculopontine tegmental nucleus.

  2023cites this paper
• Psilocin suppresses methamphetamine‐induced hyperlocomotion and acquisition of conditioned place preference via D2R‐mediated ERK signaling

  2023cites this paper
• Increasing Central Serotonin with 5-hydroxytryptophan Disrupts the Inhibition of Social Gaze in Nonhuman Primates

  2022cites this paper
• Metoclopramide as a Potential Antipsychotic Against Long-Term Methionine Exposure in Zebrafish

  2022cites this paper
• Exploring the Hypothesis of a Schizophrenia and Bipolar Disorder Continuum: Biological, Genetic and Pharmacologic Data.

  2021cites this paper
• Abnormal white matter functional connectivity density in antipsychotic-naive adolescents with schizophrenia.

  2021cites this paper
• Oxidative Stress-Related Mechanisms in Schizophrenia Pathogenesis and New Treatment Perspectives

  2021cites this paper
• Increasing Central Serotonin with 5-hydroxytryptophan Disrupts the Inhibition of Social Gaze in Nonhuman Primates

  2021influential citation
• Aripiprazole-induced obsessive–compulsive symptoms

  2021cites this paper
• Antipsychotics: Mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology

  2020cites this paper
• Genetic variability of serotonin pathway associated with schizophrenia onset, progression, and treatment

  2020cites this paper
• Fast serotonin voltammetry as a versatile tool for mapping dynamic tissue architecture: I. Responses at carbon fibers describe local tissue physiology

  2020cites this paper
• Calbindin Deficits May Underlie Dissociable Effects of 5-HT6 and mGlu7 Antagonists on Glutamate and Cognition in a Dual-Hit Neurodevelopmental Model for Schizophrenia

  2020cites this paper
• Overview of schizophrenia research and treatment in Pakistan

  2020cites this paper
• Associations between gut microbiota and Alzheimer’s disease, major depressive disorder, and schizophrenia

  2020cites this paper
• Platelet Serotonin Concentration Is Associated with Illness Duration in Schizophrenia and Chronological Age in Depression

  2020cites this paper
• Mapping brain-behavior space relationships along the psychosis spectrum

  2020cites this paper
• Large-Scale Analysis of the Diversity and Complexity of the Adult Spinal Cord Neurotransmitter Typology

  2019cites this paper
• Sensitive and Selective Measurement of Serotonin In Vivo Using Fast Cyclic Square-Wave Voltammetry.

  2019cites this paper
• The Long-term Effects of Chronic Antipsychotic Drug Treatment in Juvenile Rats on Adult Behavioural Attributes, Dopamine and Serotonin Neurotransmitter Systems

  2018cites this paper
• Pro-psychotic effects of synthetic cannabinoids: interactions with central dopamine, serotonin, and glutamate systems

  2018cites this paper
• Schizophrenia Aetiology and Drug Therapy: A Tale of Progressive Demystification and Strides in Management

  2018cites this paper
• Early antipsychotic treatment in juvenile rats elicits long-term alterations to the adult serotonin receptors

  2018cites this paper
• Early neuromodulation prevents the development of brain and behavioral abnormalities in a rodent model of schizophrenia

  2018cites this paper
• DNA methylation and gene expression of the chemokine (C-X-C motif) ligand 1 in patients with deficit and non-deficit schizophrenia.

  2018cites this paper
• Risperidone-Induced Adverse Drug Reactions and Role of DRD2 (–141 C Ins/Del) and 5HTR2C (–759 C>T) Genetic Polymorphisms in Patients with Schizophrenia

  2017cites this paper
• GluA2-Lacking AMPA Receptors and Nitric Oxide Signaling Gate Spike-Timing–Dependent Potentiation of Glutamate Synapses in the Dorsal Raphe Nucleus

  2017cites this paper
• Novel Experimental and Analysis Paradigms for Neuroimaging

  2017cites this paper
• Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia

  2017cites this paper
• In Vivo Ambient Serotonin Measurements at Carbon-Fiber Microelectrodes.

  2017cites this paper
• Melatonin attenuates behavioural deficits and reduces brain oxidative stress in a rodent model of schizophrenia.

  2017cites this paper
• Mapping Alterations to the Endogenous Elemental Distribution within the Lateral Ventricles and Choroid Plexus in Brain Disorders Using X-Ray Fluorescence Imaging

  2016cites this paper
• The risks and benefits of sun exposure 2016

  2016cites this paper
• Platelet serotonin concentration and depressive symptoms in patients with schizophrenia.

  2016cites this paper
• Alteration of transcriptional networks in the entorhinal cortex after maternal immune activation and adolescent cannabinoid exposure.

  2016cites this paper
• Pharmacogenetics and Antipsychotic Treatment Response/ Фармакогенетски Тестирања И Одговор Кон Третман Со Антипсихотоци

  2015cites this paper
• A Review of Biomarkers in Mood and Psychotic Disorders: A Dissection of Clinical vs. Preclinical Correlates

  2015cites this paper
• Serotonin transporter availability in thalamic subregions in schizophrenia: a study using 7.0-T MRI with [(11)C]DASB high-resolution PET.

  2015cites this paper
• The role of cannabinoid 1 receptor expressing interneurons in behavior.

  2014cites this paper
• A whole-brain atlas of inputs to serotonergic neurons of the dorsal and median raphe nuclei.

  2014cites this paper
• Anticonvulsant and Depressant Activity of Methanol Leaf Extract of Croton zambesicus

  2014cites this paper
• Project 1: investigating the polyclonal nature of Glioblastoma through the development of a 3-dimensional spheroid model And Project 2: Investigating TNF-α in first episode psychosis medication naïve schizophrenia patients to demographically controlled individuals and pharmacological manipulation of

  2014cites this paper
• Is the mTOR‐signalling cascade disrupted in Schizophrenia?

  2014cites this paper
• TPH2 gene polymorphisms in the regulatory region are associated with paranoid schizophrenia in Northern Han Chinese.

  2014cites this paper
• Cholinergic connectivity: it's implications for psychiatric disorders

  2013cites this paper
• Role of Lysophosphatidic Acid (LPA) in Behavioral Processes: Implications for Psychiatric Disorders

  2013cites this paper
• The Psychotic Face of the Immune System: Inflammation and Schizophrenia

  2013cites this paper
• Concerted derivatization and concentration method with dispersive liquid-liquid microextraction for liquid chromatographic analysis of 5-hydroxyindoles in human serum.

  2013cites this paper
• Recent Developments in Neurochemical Imaging in Schizophrenia: An Update

  2013cites this paper
• Recent developments in neurochemical imaging in schizophrenia: an update.

  2013cites this paper
• Peptide POP inhibitors for the treatment of the cognitive symptoms of schizophrenia.

  2013cites this paper
• Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism

  2013cites this paper
• Pharmacogenetics of clinical response to risperidone.

  2013cites this paper
• Study of a possible role of the monoamine oxidase A (MAOA) gene in paranoid schizophrenia among a Chinese population

  2012cites this paper
• Neurocognitive deficits in patients with human immunodeficiency virus infection.

  2012cites this paper
• Revisiting Thyroid Hormones in Schizophrenia

  2012cites this paper
• Şizofrenide Serotoninin Rolü Role of Serotonin in Schizophrenia

  2012cites this paper
• Behavioral animal models of antipsychotic drug actions.

  2012cites this paper
• Neonatal behavioral changes in rats with gestational exposure to lipopolysaccharide: a prenatal infection model for developmental neuropsychiatric disorders.

  2012cites this paper
• Investigation of tryptophan hydroxylase 2 (TPH2) in schizophrenia and in the response to antipsychotics.

  2012influential citation
• From the prodrome to chronic schizophrenia: the neurobiology underlying psychotic symptoms and cognitive impairments.

  2012cites this paper
• Synergistic Effect between Maternal Infection and Adolescent Cannabinoid Exposure on Serotonin 5HT1A Receptor Binding in the Hippocampus: Testing the “Two Hit” Hypothesis for the Development of Schizophrenia

  2012influential citation
• CPB-K mice a mouse model of schizophrenia? Differences in dopaminergic, serotonergic and behavioral markers compared to BALB/cJ mice.

  2012cites this paper
• REPORTED CASES DF NEW DR WORSENING OBSESSIVE AND / OR COMPULSIVE SYMPTOMS IN SCHIZOPHRENIC PATIENTS DURING TREATMENT WITH ATYPICAL ANTI PSYC H OTI C DRUGS OTHER THAN CLQZAPINE

  2012cites this paper
• Potential role of prolactin in antipsychotic‐mediated association of schizophrenia and type 2 diabetes

  2012cites this paper
• Olanzapine induced de-novo obsessive compulsive disorder in a patient with schizophrenia

  2012cites this paper
• Involvement of 5‐HT2A receptor and α2‐adrenoceptor blockade in the asenapine‐induced elevation of prefrontal cortical monoamine outflow

  2012cites this paper
• Autism Treatment Evaluation Checklist

  2012cites this paper
• Region‐specific alteration of GABAergic markers in the brain of heterozygous reeler mice

  2011cites this paper
• Schizophrenia and Autism: Both Shared and Disorder-Specific Pathogenesis Via Perinatal Inflammation?

  2011cites this paper
• Système sérotoninergique 5-HT1A et schizophrénie : étude par tomographie par émission de positons au p-[18F]MPPF chez des patients schizophrènes traités par antipsychotiques

  2011cites this paper
• dependence of the auditory evoked potential and mismatch negativity Interaction of estrogen with central serotonergic mechanisms in human sensory processing : loudness

  2011cites this paper
• Interaction of estrogen with central serotonergic mechanisms in human sensory processing: loudness dependence of the auditory evoked potential and mismatch negativity

  2011cites this paper
• Environmental and genetic modulation of dopaminergic development

  2011cites this paper
• Schizophrenia: Redox Regulation and Volume Neurotransmission

  2011cites this paper
• Caractérisations biochimique anatomique et comportementale des souris dépourvues de la protéines STOP : un modèle expérimental pour l'étude de symptômes psycho-affectifs

  2011cites this paper
• Bioequivalence & Bioavailability

  2011cites this paper
• Inflammatory processes in schizophrenia: a promising neuroimmunological target for the treatment of negative/cognitive symptoms and beyond.

  2011cites this paper
• p-Hydroxyamphetamine causes prepulse inhibition disruption in mice: contribution of serotonin neurotransmission.

  2011cites this paper
• Oral administration of glycine increases extracellular serotonin but not dopamine in the prefrontal cortex of rats

  2011cites this paper
• Comparative Bioavailability of Two Quetiapine Formulations in HealthyVolunteers after a Single Dose Administration

  2011cites this paper
• Role of lysophosphatidic acid as lipid mediator in behavior

  2011cites this paper
• The effect of serotonergic lesions in the medial prefrontal cortex on psychotomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats

  2011cites this paper
• Anti-inflammatory signaling in schizophrenia.

  2011cites this paper
• p-Hydroxyamphetamine causes prepulse inhibition disruptions in mice: contribution of dopamine neurotransmission.

  2010cites this paper
• Neurochemical imaging in schizophrenia.

  2010cites this paper
• In vivo Serotonin-Sensitive Binding of [11C]CUMI-101: A Serotonin 1A Receptor Agonist Positron Emission Tomography Radiotracer

  2010cites this paper
• In vivo modulation of the firing activity of putative slow- and fast-spiking interneurons in the medial prefrontal cortex by 5-HT3 receptors in 6-hydroxydopamine-induced Parkinsonian rats.

  2010cites this paper
• Current pharmacological models of social withdrawal in rats: relevance to schizophrenia

  2010cites this paper
• Acute dopamine and/or serotonin depletion does not modulate mismatch negativity (MMN) in healthy human participants

  2010cites this paper
• Eye movements and schizophrenia risk genes. Associations of the putative schizophrenia risk genes COMT and NRG-1 with smooth pursuit and antisaccade eye movement endophenotypes in schizophrenia patients and healthy controls drawn from the homogenous Icelandic population

  2010cites this paper
• Serotonergic lesions of the dorsal hippocampus differentially modulate locomotor hyperactivity induced by drugs of abuse in rats: implications for schizophrenia

  2009cites this paper
• Solubilized phenyl-pyrazole ureas as potent, selective 5-HT(2A) inverse-agonists and their application as antiplatelet agents.

  2009cites this paper
• Neural basis of psychosis-related behaviour in the infection model of schizophrenia.

  2009cites this paper
• Vilazodone: A 5‐HT1A Receptor Agonist/Serotonin Transporter Inhibitor for the Treatment of Affective Disorders

  2009cites this paper
• Prenatal immune activation leads to multiple changes in basal neurotransmitter levels in the adult brain: implications for brain disorders of neurodevelopmental origin such as schizophrenia.

  2009cites this paper
• Serotonin facilitates long‐term depression induction in prefrontal cortex via p38 MAPK/Rab5‐mediated enhancement of AMPA receptor internalization

  2008cites this paper